PWA
CVS icon

Providence Wealth Advisors’s CVS Health CVS Stock Holding History

Providence Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,534
Closed -$627K – 80
2024
Q1 		$627K Sell
8,534
-4,279
-33% -$327K 0.54% 53
2023
Q4 		$694K Buy
12,813
+4,143
+48% +$295K 0.63% 51
2023
Q3 		$601K Sell
8,670
-572
-6% -$40.5K 0.67% 46
2023
Q2 		$643K Sell
9,242
-1,208
-12% -$86K 0.71% 45
2023
Q1 		$766K Sell
10,450
-273
-3% -$22.9K 0.57% 55
2022
Q4 		$971K Sell
10,723
-136
-1% -$13.1K 0.72% 45
2022
Q3 		$1.1M Sell
10,859
-462
-4% -$45.7K 0.83% 40
2022
Q2 		$1.05M Buy
11,321
+515
+5% +$50.3K 0.76% 43
2022
Q1 		$1.09M Buy
10,806
+96
+0.9% +$10.1K 0.7% 46
2021
Q4 		$1.12M Buy
10,710
+552
+5% +$51K 0.7% 46
2021
Q3 		$843K Sell
10,158
-382
-4% -$32K 0.59% 49
2021
Q2 		$861K Sell
10,540
-33
-0.3% -$2.7K 0.59% 49
2021
Q1 		$795K Buy
10,573
+418
+4% +$30.4K 0.58% 51
2020
Q4 		$688K Buy
10,155
+168
+2% +$10.9K 0.57% 54
2020
Q3 		$583K Sell
9,987
-428
-4% -$26.6K 0.58% 53
2020
Q2 		$677K Sell
10,415
-892
-8% -$56.2K 0.69% 47
2020
Q1 		$660K Buy
11,307
+1,392
+14% +$92.9K 0.8% 43
2019
Q4 		$733K Sell
9,915
-758
-7% -$53.2K 0.67% 55
2019
Q3 		$673K Buy
10,673
+233
+2% +$13.8K 0.6% 55
2019
Q2 		$570K Sell
10,440
-364
-3% -$19.6K 0.53% 59
2019
Q1 		$579K Buy
10,804
+919
+9% +$56.7K 0.54% 59
2018
Q4 		$644K Sell
9,885
-418
-4% -$31.2K 0.71% 50
2018
Q3 		$811K Sell
10,303
-370
-3% -$26.5K 0.74% 47
2018
Q2 		$687K Sell
10,673
-92
-0.9% -$6.06K 0.67% 53
2018
Q1 		$657K Buy
+10,765
New +$772K 0.97% 40

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Providence Wealth Advisors's CVS Position: Q2 2024 in Review

Providence Wealth Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 8,534 shares — an estimated $627K sold.

Providence Wealth Advisors first reported a position in CVS in Q1 2018 and held it in 25 quarters. The position peaked at $1.12M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Providence Wealth Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Providence Wealth Advisors sold 8,534 CVS Health shares in Q2 2024, an estimated $627K.
  • Providence Wealth Advisors first reported a position in CVS Health in Q1 2018 and held it in 25 quarters.
  • Providence Wealth Advisors's CVS Health position peaked at $1.12M in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Providence Wealth Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.